Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients. Tamoxifen is known to reduce the risk of breast cancer in women at high risk and also reduces mammographic breast density in a preventive setting.